Showing results (1371-1380 of 3,105) with videos related to
Sort By:
Pageof 311
Drug Safety|September 27, 2014
Stimulated reporting: the impact of US food and drug administration-issued alerts on the adverse event reporting system (FAERS)Keith B Hoffman, Andrea R Demakas, Mo Dimbil, et al.Drug Safety|September 27, 2014
Relevance of foreign alerts and newsletters for the medication errors reporting programme in the Netherlands: an explorative retrospective studyKa-Chun Cheung, Patricia M L A van den Bemt, Marcel L Bouvy, et al.Drug Safety|August 6, 2015
Safety of Perflutren Ultrasound Contrast Agents: A Disproportionality Analysis of the US FAERS DatabaseManfred Hauben, Eric Y Hung, Kelly C Hanretta, et al.Drug Safety|August 13, 2014
Comparison of pregnancy and lactation labeling for attention-deficit hyperactivity disorder drugs marketed in Australia, the USA, Denmark, and the UKPernille Warrer, Lise Aagaard, Ebba Holme HansenDrug Safety|August 1, 2014
Cardiovascular risk with non-steroidal anti-inflammatory drugs: clinical implicationsAlfonso E Bello, Robert J HoltDrug Safety|November 2, 2013
Profiling cumulative proportional reporting ratios of drug-induced liver injury in the FDA Adverse Event Reporting System (FAERS) databaseAllen D Brinker, Jenna Lyndly, Joseph Tonning, et al.Drug Safety|July 16, 2014
A comparison of active adverse event surveillance systems worldwideYu-Lin Huang, Jinhee Moon, Jodi B SegalDrug Safety|April 22, 2016
Pharmacokinetics, Efficacy, and Safety of Hepatitis C Virus Drugs in Patients with Liver and/or Renal ImpairmentElise J Smolders, Clara T M M de Kanter, Bart van Hoek, et al.Drug Safety|July 27, 2017
Drug-Induced Dental Caries: A Disproportionality Analysis Using Data from VigiBaseEmilie Patras de Campaigno, Inès Kebir, Jean-Louis Montastruc, et al.Drug Safety|August 7, 2017
Channeling in the Use of Nonprescription Paracetamol and Ibuprofen in an Electronic Medical Records Database: Evidence and ImplicationsRachel B Weinstein, Patrick Ryan, Jesse A Berlin, et al.Pageof 311